Ahead of peak transmission season, Nigeria’s Borno state launched a seasonal malarial chemoprevention campaign on July 14, delivering the antimalarial combination of amodiaquine plus sulfadoxine-pyrimethamine door-to-door to 2 million children ages 3–59 months. WHO
Menu